Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.2%

285 terminated/withdrawn out of 1760 trials

Success Rate

78.6%

-8.0% vs industry average

Late-Stage Pipeline

9%

167 trials in Phase 3/4

Results Transparency

51%

534 of 1045 completed trials have results

Key Signals

211 recruiting534 with results171 terminated114 withdrawn

Enrollment Performance

Analytics

N/A
859(60.1%)
Phase 2
227(15.9%)
Phase 1
129(9.0%)
Phase 4
107(7.5%)
Phase 3
60(4.2%)
Early Phase 1
48(3.4%)
1430Total
N/A(859)
Phase 2(227)
Phase 1(129)
Phase 4(107)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (1760)

Showing 20 of 1760 trials
NCT05568264Not ApplicableActive Not Recruiting

Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

Role: collaborator

NCT05913687Active Not Recruiting

Automated Imaging Differentiation of Parkinsonism

Role: collaborator

NCT07097103Not ApplicableNot Yet Recruiting

Parkinson's Research In Metagenomic Early Stage Biomarkers

Role: collaborator

NCT07732179Not ApplicableRecruiting

Aromatherapy and Music Impact on Nurses' Stress at Work

Role: lead

NCT05719714Phase 1Active Not Recruiting

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

Role: lead

NCT07179822Not ApplicableRecruiting

Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)

Role: collaborator

NCT07604272Phase 1Recruiting

Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in Males

Role: lead

NCT05859061Not ApplicableCompleted

Cryoanalgesia Study

Role: lead

NCT07293689Recruiting

PREcision MEDicine In Achalasia (PREMEDIA) - Cohort

Role: lead

NCT07728708Not Yet Recruiting

Effects of Axatilimab on Skin in Chronic Graft-versus-Host Disease

Role: lead

NCT06657976Phase 2Recruiting

Response to Exercise and Nitric Oxide in PAD

Role: lead

NCT07293650Phase 3Recruiting

PREcision MEDicine In Achalasia (PREMEDIA)

Role: lead

NCT07729436Not ApplicableNot Yet Recruiting

Healthy Options At Pantries (HOAP) Study

Role: lead

NCT04557748Completed

LURN: Urinary Urgency Phenotyping Protocol

Role: collaborator

NCT05627596Phase 2Completed

Free Samples for Health

Role: collaborator

NCT07469176Not ApplicableNot Yet Recruiting

Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With Down Syndrome

Role: lead

NCT07724652Not ApplicableNot Yet Recruiting

The AYA Oncology Self-care Movement

Role: lead

NCT06907472Not ApplicableActive Not Recruiting

Diabetes Management for Primary Healthcare Centers.

Role: collaborator

NCT05983250Phase 3Active Not Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

Role: collaborator

NCT06170450Not ApplicableCompleted

Cyclic Versus Continuous Sacral Neuromodulation for LUTS

Role: collaborator